skip to main content
Idioma:
Resultados 1 2 3 4 5 next page
Mostrar Somente
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Nucleotide Analogues as Inhibitors of SARS-CoV‑2 Polymerase, a Key Drug Target for COVID-19
Nucleotide Analogues as Inhibitors of SARS-CoV‑2 Polymerase, a Key Drug Target for COVID-19
Material Type:
Artigo 		Adicionar ao Meu Espaço

Nucleotide Analogues as Inhibitors of SARS-CoV‑2 Polymerase, a Key Drug Target for COVID-19

Chien, Minchen ; Anderson, Thomas K ; Jockusch, Steffen ; Tao, Chuanjuan ; Li, Xiaoxu ; Kumar, Shiv ; Russo, James J ; Kirchdoerfer, Robert N ; Ju, Jingyue

Journal of proteome research, 2020-11, Vol.19 (11), p.4690-4697 [Periódico revisado por pares]

United States: American Chemical Society

Texto completo disponível

Citações Citado por
2
The FDA-approved drug sofosbuvir inhibits Zika virus infection
The FDA-approved drug sofosbuvir inhibits Zika virus infection
Material Type:
Artigo 		Adicionar ao Meu Espaço

The FDA-approved drug sofosbuvir inhibits Zika virus infection

Bullard-Feibelman, Kristen M. ; Govero, Jennifer ; Zhu, Zhe ; Salazar, Vanessa ; Veselinovic, Milena ; Diamond, Michael S. ; Geiss, Brian J.

Antiviral research, 2017-01, Vol.137, p.134-140 [Periódico revisado por pares]

Netherlands: Elsevier B.V

Texto completo disponível

Citações Citado por
3
Pharmacokinetic, Pharmacodynamic, and Drug-Interaction Profile of the Hepatitis C Virus NS5B Polymerase Inhibitor Sofosbuvir
Pharmacokinetic, Pharmacodynamic, and Drug-Interaction Profile of the Hepatitis C Virus NS5B Polymerase Inhibitor Sofosbuvir
Material Type:
Artigo 		Adicionar ao Meu Espaço

Pharmacokinetic, Pharmacodynamic, and Drug-Interaction Profile of the Hepatitis C Virus NS5B Polymerase Inhibitor Sofosbuvir

Kirby, Brian J. ; Symonds, William T. ; Kearney, Brian P. ; Mathias, Anita A.

Clinical pharmacokinetics, 2015-07, Vol.54 (7), p.677-690 [Periódico revisado por pares]

Cham: Springer International Publishing

Texto completo disponível

Citações Citado por
4
Sofosbuvir terminated RNA is more resistant to SARS-CoV-2 proofreader than RNA terminated by Remdesivir
Sofosbuvir terminated RNA is more resistant to SARS-CoV-2 proofreader than RNA terminated by Remdesivir
Material Type:
Artigo 		Adicionar ao Meu Espaço

Sofosbuvir terminated RNA is more resistant to SARS-CoV-2 proofreader than RNA terminated by Remdesivir

Jockusch, Steffen ; Tao, Chuanjuan ; Li, Xiaoxu ; Chien, Minchen ; Kumar, Shiv ; Morozova, Irina ; Kalachikov, Sergey ; Russo, James J ; Ju, Jingyue

Scientific reports, 2020-10, Vol.10 (1), p.16577, Article 16577 [Periódico revisado por pares]

England: Nature Publishing Group UK

Texto completo disponível

Citações Citado por
5
Sofosbuvir Inhibits Hepatitis E Virus Replication In Vitro and Results in an Additive Effect When Combined With Ribavirin
Sofosbuvir Inhibits Hepatitis E Virus Replication In Vitro and Results in an Additive Effect When Combined With Ribavirin
Material Type:
Artigo 		Adicionar ao Meu Espaço

Sofosbuvir Inhibits Hepatitis E Virus Replication In Vitro and Results in an Additive Effect When Combined With Ribavirin

Dao Thi, Viet Loan ; Debing, Yannick ; Wu, Xianfang ; Rice, Charles M ; Neyts, Johan ; Moradpour, Darius ; Gouttenoire, Jérôme

Gastroenterology (New York, N.Y. 1943), 2016, Vol.150 (1), p.82-85.e4 [Periódico revisado por pares]

United States: Elsevier Inc

Texto completo disponível

Citações Citado por
6
Emergence of resistance-associated variants during sofosbuvir treatment in chronically infected hepatitis E patients
Emergence of resistance-associated variants during sofosbuvir treatment in chronically infected hepatitis E patients
Material Type:
Artigo 		Adicionar ao Meu Espaço

Emergence of resistance-associated variants during sofosbuvir treatment in chronically infected hepatitis E patients

Gömer, André ; Klöhn, Mara ; Jagst, Michelle ; Nocke, Maximilian K ; Pischke, Sven ; Horvatits, Thomas ; Schulze Zur Wiesch, Julian ; Müller, Tobias ; Hardtke, Svenja ; Cornberg, Markus ; Wedemeyer, Heiner ; Behrendt, Patrick ; Steinmann, Eike ; Todt, Daniel

Hepatology (Baltimore, Md.), 2023-12, Vol.78 (6), p.1882-1895 [Periódico revisado por pares]

United States

Texto completo disponível

Citações Citado por
7
Repurposing Nucleoside Analogs for Human Coronaviruses
Repurposing Nucleoside Analogs for Human Coronaviruses
Material Type:
Artigo 		Adicionar ao Meu Espaço

Repurposing Nucleoside Analogs for Human Coronaviruses

Zandi, Keivan ; Amblard, Franck ; Musall, Katie ; Downs-Bowen, Jessica ; Kleinbard, Ruby ; Oo, Adrian ; Cao, Dongdong ; Liang, Bo ; Russell, Olivia O ; McBrayer, Tamara ; Bassit, Leda ; Kim, Baek ; Schinazi, Raymond F

Antimicrobial agents and chemotherapy, 2020-12, Vol.65 (1) [Periódico revisado por pares]

United States: American Society for Microbiology

Texto completo disponível

Citações Citado por
8
The clinically approved antiviral drug sofosbuvir inhibits Zika virus replication
The clinically approved antiviral drug sofosbuvir inhibits Zika virus replication
Material Type:
Artigo 		Adicionar ao Meu Espaço

The clinically approved antiviral drug sofosbuvir inhibits Zika virus replication

Sacramento, Carolina Q ; de Melo, Gabrielle R ; de Freitas, Caroline S ; Rocha, Natasha ; Hoelz, Lucas Villas Bôas ; Miranda, Milene ; Fintelman-Rodrigues, Natalia ; Marttorelli, Andressa ; Ferreira, André C ; Barbosa-Lima, Giselle ; Abrantes, Juliana L ; Vieira, Yasmine Rangel ; Bastos, Mônica M ; de Mello Volotão, Eduardo ; Nunes, Estevão Portela ; Tschoeke, Diogo A ; Leomil, Luciana ; Loiola, Erick Correia ; Trindade, Pablo ; Rehen, Stevens K ; Bozza, Fernando A ; Bozza, Patrícia T ; Boechat, Nubia ; Thompson, Fabiano L ; de Filippis, Ana M B ; Brüning, Karin ; Souza, Thiago Moreno L

Scientific reports, 2017-01, Vol.7 (1), p.40920-40920, Article 40920 [Periódico revisado por pares]

England: Nature Publishing Group

Texto completo disponível

Citações Citado por
9
In vitro antiviral activity of the anti-HCV drugs daclatasvir and sofosbuvir against SARS-CoV-2, the aetiological agent of COVID-19
In vitro antiviral activity of the anti-HCV drugs daclatasvir and sofosbuvir against SARS-CoV-2, the aetiological agent of COVID-19
Material Type:
Artigo 		Adicionar ao Meu Espaço

In vitro antiviral activity of the anti-HCV drugs daclatasvir and sofosbuvir against SARS-CoV-2, the aetiological agent of COVID-19

Sacramento, Carolina Q ; Fintelman-Rodrigues, Natalia ; Temerozo, Jairo R ; Da Silva, Aline de Paula Dias ; Dias, Suelen da Silva Gomes ; da Silva, Carine dos Santos ; Ferreira, André C ; Mattos, Mayara ; Pão, Camila R R ; de Freitas, Caroline S ; Soares, Vinicius Cardoso ; Hoelz, Lucas Villas Bôas ; Fernandes, Tácio Vinício Amorim ; Branco, Frederico Silva Castelo ; Bastos, Mônica Macedo ; Boechat, Núbia ; Saraiva, Felipe B ; Ferreira, Marcelo Alves ; Jockusch, Steffen ; Wang, Xuanting ; Tao, Chuanjuan ; Chien, Minchen ; Xie, Wei ; Patel, Dinshaw ; Garzia, Aitor ; Tuschl, Thomas ; Russo, James J ; Rajoli, Rajith K R ; Pedrosa, Carolina S G ; Vitória, Gabriela ; Souza, Letícia R Q ; Goto-Silva, Livia ; Guimarães, Marilia Zaluar ; Rehen, Stevens K ; Owen, Andrew ; Bozza, Fernando A ; Bou-Habib, Dumith Chequer ; Ju, Jingyue ; Bozza, Patrícia T ; Souza, Thiago Moreno L

Journal of antimicrobial chemotherapy, 2021-06, Vol.76 (7), p.1874-1885 [Periódico revisado por pares]

England: Oxford University Press

Texto completo disponível

Citações Citado por
10
Sofosbuvir/velpatasvir for 12 vs. 6 weeks for the treatment of recently acquired hepatitis C infection
Sofosbuvir/velpatasvir for 12 vs. 6 weeks for the treatment of recently acquired hepatitis C infection
Material Type:
Artigo 		Adicionar ao Meu Espaço

Sofosbuvir/velpatasvir for 12 vs. 6 weeks for the treatment of recently acquired hepatitis C infection

Matthews, Gail V. ; Bhagani, Sanjay ; Van der Valk, Marc ; Rockstroh, Juergen ; Feld, Jordan J. ; Rauch, Andri ; Thurnheer, Christine ; Bruneau, Julie ; Kim, Arthur ; Hellard, Margaret ; Shaw, David ; Gane, Ed ; Nelson, Mark ; Ingiliz, Patrick ; Applegate, Tanya L. ; Grebely, Jason ; Marks, Phillipa ; Martinello, Marianne ; Petoumenos, Kathy ; Dore, Gregory J. ; van der Valk, Marc ; Hellard, Margaret ; Gane, Ed ; Rauch, Andri ; Bruneau, Julie ; Kim, Arthur ; Bhagani, Sanjay ; Dore, Greg ; Marks, Pip ; Matthews, Gail ; Grebely, Jason ; Petoumenos, Kathy ; Martinello, Marianne ; Applegate, Tanya ; Feld, Jordan ; Rockstroh, Jürgen ; Matthews, Gail ; Marks, Pip ; Amjad, Sophia ; Tu, Elise ; Petoumenos, Kathy ; Tamaddoni, Mahshid ; van der Valk, Marc ; Hellard, Margaret ; Gane, Ed ; Thurnheer, Maria Christine ; Gilleece, Yvonne ; Bruneau, Julie ; Nelson, Mark ; Fraser, Chris ; Moriggia, Alberto ; Lutz, Thomas ; Moon, Juhi ; Read, Phillip ; Kim, Arthur Y. ; Ustianowski, Andrew ; Cordes, Christiane ; Shaw, David ; Bhagani, Sanjay ; Sasadeusz, Joe ; Hull, Mark ; Dore, Greg ; Feld, Jordan ; Rockstroh, Jürgen ; Braun, Dominique ; Ingiliz, Patrick

Journal of hepatology, 2021-10, Vol.75 (4), p.829-839 [Periódico revisado por pares]

Netherlands: Elsevier B.V

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Revistas revisadas por pares (513)

Refinar Meus Resultados

Tipo de Recurso 

  1. Artigos  (520)
  2. Book Chapters  (5)
  3. Livros  (1)
  4. Mais opções open sub menu

Data de Publicação 

De até
Refinar
  1. Antes de2012  (5)
  2. 2012Até2014  (61)
  3. 2015Até2017  (180)
  4. 2018Até2021  (200)
  5. Após 2021  (82)
  6. Mais opções open sub menu

Idioma 

  1. Inglês  (524)
  2. Japonês  (67)
  3. Português  (4)
  4. Francês  (1)
  5. Espanhol  (1)
  6. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.